Immuron (ASX:IMC) Steps into Spotlight at Emerging Growth Conference

IMC

1 min read | April 30, 2026 11:12 AM AEST | By Sonal Goyal

Google News:

Immuron (ASX:IMC) Steps into Spotlight at Emerging Growth Conference — Image source: Company update

Recent News

Big Four Bank Dividends Face a New Reality in 2026

ASX Consumer Split: Staples Calm, Discretionary Jitters

Why Are Defensive Stocks Like (ASX:WOW) and (ASX:COL) Slipping in ASX...

Telstra (ASX:TLS) Stays the Steady Hand for ASX Communication Income

Make Kalkine Media
My Trusted Source

Highlights

Immuron CEO Steven Lydeamore will present at the Emerging Growth Conference via a virtual session on 7 May 2026.

The virtual presentation will provide an opportunity to engage with investors and market participants.

Immuron is a commercial and clinical-stage Australian biopharmaceutical company focused on orally delivered antibody therapies.

The company markets its flagship products Travelan® and Protectyn®, both listed on the Australian Register of Therapeutic Goods (TGA).

Immuron Limited (ASX:IMC) (NASDAQ:IMRN) has reported that its Chief Executive Officer, Steven Lydeamore, will participate in the Emerging Growth Conference through a virtual session. The presentation is scheduled for Thursday, 7 May 2026, and is expected to run for approximately 30 minutes.

The presentation forms part of the conference program, which features a range of listed companies addressing investors and market participants.

About the Company

IMC shares traded at AUD 0.029 per share on 29 April 2026.

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.